Keyphrases
Adverse Events
25%
Area under the Concentration Curve
75%
Atenolol
25%
Bisoprolol
25%
Cardiology
100%
Carvedilol
25%
Cmax
50%
Coefficient of Variation
50%
Dynamic Characteristics
25%
High Variability
25%
Labetalol
25%
Low-to-moderate
25%
Medical Treatment
25%
Metoprolol
50%
Nadolol
25%
Patient Characteristics
25%
Personalized Approach
25%
Pharmacogenetics
25%
Pharmacokinetic Study
50%
Pharmacokinetic Variability
100%
Pharmacokinetics
25%
Pindolol
25%
Plasma Concentration
25%
Propranolol
25%
PubMed
25%
Sotalol
25%
Steady State
50%
Steady-state Studies
25%
Treatment Effect
25%
β-Adrenergic Blocking Agent
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
14%
Atenolol
14%
Beta Adrenergic Receptor Blocking Agent
100%
Bisoprolol
14%
Carvedilol
14%
Combination Therapy
14%
Labetalol
14%
Metoprolol
28%
Nadolol
14%
Nebivolol
14%
Pharmacogenetics
14%
Pharmacokinetic
100%
Pindolol
14%
Propranolol
14%
Sotalol
14%